CD274 and cancer: In terms of the canonical pathway, the antigen presentation pathway was the most significant (p = 1.31E-03), followed by PD-1, PD-L1 cancer immunotherapy pathway (p = 1.62E-02) and B cell development, (p = 1.64E-02).